Astrocytoma: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
No edit summary
imported>Meg Taylor
No edit summary
 
Line 5: Line 5:
  | url = http://neurosurgery.mgh.harvard.edu/newwhobt.htm
  | url = http://neurosurgery.mgh.harvard.edu/newwhobt.htm
  | year = 2006
  | year = 2006
  | publisher = Neurosurgical Service, [[Massachussetts General Hospital]]}}</ref>
  | publisher = Neurosurgical Service, [[Massachusetts General Hospital]]}}</ref>


{| class="wikitable"
{| class="wikitable"
Line 25: Line 25:
| I, II
| I, II
| 1 or 2
| 1 or 2
| 1: No criteria fulfilled; 2: one criterian, usually nuclear atypia
| 1: No criteria fulfilled; 2: one criterion, usually nuclear atypia
|-
|-
|Anaplastic  
|Anaplastic  

Latest revision as of 06:34, 28 September 2013

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In neurology and oncology, an astrocytoma is a neoplasm of the central nervous system, which originates in normal astrocytes. Under the 1993 World Health Association criteria, a glioblastoma can be considered a "high-grade" (Grade IV) astrocytoma; grade III anaplastic astrocytomas are also malignant. The lower-grade astrocytomas may progress to higher-grade [1]

WHO designation WHO grade Kernohan grade St. Anne/Mayo grade St. Anne/Mayo criteria
pilocytic astrocytoma I I excluded
Astrocytoma II I, II 1 or 2 1: No criteria fulfilled; 2: one criterion, usually nuclear atypia
Anaplastic II II, III 3 Two criteria: nuclear atypia and mitosis
Malignant astrocytoma and glioblastoma IV III, IV 4 Three or four; add necrosis

References